{"nct_id":"NCT00654420","title":"A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007)","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2008-03-19","start_date_type":"ACTUAL","primary_completion_date":"2009-11-25","primary_completion_date_type":"ACTUAL","completion_date":"2012-02-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}